Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

Lagendijk, Mirelle; Saadatmand, Sepideh; Koppert, Linetta B; Tilanus-Linthorst, Madeleine M A; de Weerd, Vanja; Ramírez-Moreno, Raquel; Smid, Marcel; Sieuwerts, Anieta M; Martens, John W M.

Affiliation

Lagendijk M; Department of Surgical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Saadatmand S; Department of Surgical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Koppert LB; Department of Surgical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Tilanus-Linthorst MMA; Department of Surgical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Ramírez-Moreno R; Department of Medical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, EA 3075, Rotterdam, The Netherlands.
Martens JWM; Cancer Genomics Centre Netherlands, Erasmus University MC, CN 3015, Rotterdam, The Netherlands.

Oncotarget ; 9(62): 32096, 2018 08 10.

Article in En | MEDLINE | ID: mdl-30174799

ABSTRACT

[This corrects the article DOI 10.18632/oncotarget.25262.].

Full text: 1 Database: MEDLINE Language: En Journal: Oncotarget Year: 2018 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Language: En Journal: Oncotarget Year: 2018 Type: Article Affiliation country: Netherlands